(Q35127786)

6 August 2017

1 reference

title

Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine (English)

1 reference

6 August 2017

Pharmacogenetics of Drug Metabolising Enzymes: Importance for Personalised Medicine (English)

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

2 January 2024

author name string

Mikael Oscarson

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12747605

2 January 2024

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://www.degruyter.com/document/doi/10.1515/CCLM.2003.087/pdf

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Clinical Chemistry and Laboratory Medicine

2 January 2024

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

573-580

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Pharmacogenetics for the individualization of psychiatric treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Beta-adrenergic receptor polymorphisms and drug responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Plasma cholinesterase: gene and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Study of glucose-6-phosphate dehydrogenase: history and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Update on pharmacogenetics in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.087

Genotype or phenotype: the definition of a pharmacogenetic polymorphism

21 January 2018

9

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds

2 January 2024

17

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man

2 January 2024

20

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes

2 January 2024

33

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

2 January 2024

Molecular Pharmacology

34

46

452

Johansson I

1994

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

2 January 2024

36

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

2 January 2024

40

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus

2 January 2024

47

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

2 January 2024

48

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

2 January 2024

49

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient

2 January 2024

55

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

2 January 2024

59

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

2 January 2024

61

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

Drug Metabolism and Disposition

2 January 2024

63

29

596

Innocenti F

2001

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.087

2 January 2024

Identifiers

1 reference

6 August 2017

1 reference